Next Article in Journal
Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial
Previous Article in Journal
Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(17), 4228; https://doi.org/10.3390/cancers14174228
Action Date Notes Link
article pdf uploaded. 30 August 2022 17:36 CEST Version of Record https://www.mdpi.com/2072-6694/14/17/4228/pdf-vor
article supplementary file uploaded. 30 August 2022 17:36 CEST - https://www.mdpi.com/2072-6694/14/17/4228#supplementary
article pdf uploaded. 31 August 2022 06:09 CEST Updated version of record https://www.mdpi.com/2072-6694/14/17/4228/pdf-vor
article xml file uploaded 2 September 2022 05:16 CEST Original file -
article xml uploaded. 2 September 2022 05:16 CEST Update https://www.mdpi.com/2072-6694/14/17/4228/xml
article pdf uploaded. 2 September 2022 05:16 CEST Updated version of record https://www.mdpi.com/2072-6694/14/17/4228/pdf
article html file updated 2 September 2022 05:17 CEST Original file https://www.mdpi.com/2072-6694/14/17/4228/html
Back to TopTop